Skip to main content

Gold(III) Complexes Containing N-Heterocyclic Carbene Ligand Serve as Dual Fluorescent Thiol “Switch-On” Probe and Anticancer Agent

  • Chapter
  • First Online:
Anti-Cancer N-Heterocyclic Carbene Complexes of Gold(III), Gold(I) and Platinum(II)

Part of the book series: Springer Theses ((Springer Theses))

  • 552 Accesses

Abstract

Cellular thiol level is associated with cellular redox balances that are linked up with various diseases such as cancers and AIDS [16]. Due to the high binding affinity toward thiols, soft metal ions and their complexes are usually utilized in the design of metal-based thiol probes as well as new anticancer drug leads which could specifically target thiol-/selenol-containing proteins/enzymes [711]. Au(I) is one kind of soft metal ions having high binding affinity toward-SH groups and can be generated by the reduction of Au(III) with thiols. Most reported Au(III) complexes are known to be readily reduced to Au(I) and/or Au(0) by cellular thiols (e.g., glutathione, GSH) [7, 1214]. In view of the fact that Au(III) is 4-coordinated, whereas Au(I) is usually 2-coordinated, reduction of Au(III) to Au(I) is accompanied by the release of coordinated ligand(s).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Herzenberg LA, De Rosa SC, Dubs JG, Roederer M, Anderson MT, Ela SW, Deresinski SC, Herzenberg LA (1997) Glutathione deficiency is associated with impaired survival in hiv disease. Proc Natl Acad Sci USA 94(5):1967–1972

    Article  CAS  Google Scholar 

  2. Rahman I, MacNee W (2000) Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches. Free Radical Biol Med 28(9):1405–1420

    Article  CAS  Google Scholar 

  3. Escobedo J, Rusin O, Wang W, Alptürk O, Kim KK, Xu X, Strongin R (2006) Detection of biological thiols. In: Geddes C, Lakowicz J (eds) Reviews in fluorescence 2006, vol 2006. Springer, US, pp 139–162. doi:10.1007/0-387-33016-X_6

  4. Zhang M, Yu M, Li F, Zhu M, Li M, Gao Y, Li L, Liu Z, Zhang J, Zhang D, Yi T, Huang C (2007) A highly selective fluorescence turn-on sensor for cysteine/homocysteine and its application in bioimaging. J Am Chem Soc 129(34):10322–10323

    Article  CAS  Google Scholar 

  5. Bindoli A, Rigobello MP, Scutari G, Gabbiani C, Casini A, Messori L (2009) Thioredoxin reductase: a aarget for gold compounds acting as potential anticancer drugs. Coord Chem Rev 253(11–12):1692–1707

    Article  CAS  Google Scholar 

  6. Zhao Q, Huang C, Li F (2011) Phosphorescent heavy-metal complexes for bioimaging. Chem Soc Rev 40(5):2508–2524

    Article  CAS  Google Scholar 

  7. Sadler PJ, Sue RE (1994) The chemistry of gold drugs. Met-Based Drugs 1(2–3):107–144

    Article  CAS  Google Scholar 

  8. Chow C-F, Chiu BKW, Lam MHW, Wong W-Y (2003) A trinuclear heterobimetallic Ru(II)/Pt(II) complex as a chemodosimeter selective for sulfhydryl-containing amino acids and peptides. J Am Chem Soc 125(26):7802–7803

    Article  CAS  Google Scholar 

  9. Shao N, Jin JY, Cheung SM, Yang RH, Chan WH, Mo T (2006) A spiropyran-based ensemble for visual recognition and quantification of cysteine and homocysteine at physiological levels. Angew Chem Int Ed 45(30):4944–4948

    Article  CAS  Google Scholar 

  10. Yang Y-K, Shim S, Tae J (2010) Rhodamine-sugar based turn-on fluorescent probe for the detection of cysteine and homocysteine in water. Chem Commun 46(41):7766–7768

    Article  CAS  Google Scholar 

  11. Chen X, Zhou Y, Peng X, Yoon J (2010) Fluorescent and colorimetric probes for detection of thiols. Chem Soc Rev 39(6):2120–2135

    Article  CAS  Google Scholar 

  12. Shaw CF III (1999) Gold-Based Therapeutic Agents. Chem Rev 99(9):2589–2600

    Article  CAS  Google Scholar 

  13. Nobili S, Mini E, Landini I, Gabbiani C, Casini A, Messori L (2010) Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies. Med Res Rev 30(3):550–580

    CAS  Google Scholar 

  14. Berners-Price SJ, Filipovska A (2011) Gold compounds as therapeutic agents for human diseases. Metallomics 3(9):863–873

    Article  CAS  Google Scholar 

  15. Messori L, Abbate F, Marcon G, Orioli P, Fontani M, Mini E, Mazzei T, Carotti S, O’Connell T, Zanello P (2000) Gold(III) complexes as potential antitumor agents: solution chemistry and cytotoxic properties of some selected Gold(III) compounds. J Med Chem 43(19):3541–3548

    Article  CAS  Google Scholar 

  16. Pizarro AM, Habtemariam A, Sadler PJ (2010) Activation mechanisms for organometallic anticancer complexes. Top Organomet Chem 32 (Medicinal Organometallic Chemistry):21–56

    Google Scholar 

  17. Che C-M, Siu F-M (2010) Metal Complexes in Medicine with a Focus on Enzyme Inhibition. Curr Opin Chem Biol 14(2):255–261

    Article  CAS  Google Scholar 

  18. Che C-M, Sun RW-Y (2011) Therapeutic applications of gold complexes: lipophilic Gold(III) cations and Gold(I) complexes for anti-cancer treatment. Chem Commun 47(34):9554–9560

    Article  CAS  Google Scholar 

  19. Berners-Price SJ, Mirabelli CK, Johnson RK, Mattern MR, McCabe FL, Faucette LF, Sung C-M, Mong S-M, Sadler PJ, Crooke ST (1986) In vivo antitumor activity and in vitro cytotoxic properties of Bis[1,2-bis(diphenylphosphino)ethane]gold(I) chloride. Cancer Res 46(11):5486–5493

    CAS  Google Scholar 

  20. Urig S, Fritz-Wolf K, Réau R, Herold-Mende C, Tóth K, Davioud-Charvet E, Becker K (2006) Undressing of phosphine Gold(I) complexes as irreversible inhibitors of human disulfide reductases. Angew Chem Int Ed 45(12):1881–1886

    Article  CAS  Google Scholar 

  21. Meggers E (2009) Targeting proteins with metal complexes. Chem Commun 9:1001–1010

    Article  Google Scholar 

  22. Ott I, Qian X, Xu Y, Vlecken DHW, Marques IJ, Kubutat D, Will J, Sheldrick WS, Jesse P, Prokop A, Bagowski CP (2009) A Gold(I) phosphine complex containing naphthalimide ligand functions as a TrxR inhibiting antiproliferative agent and angiogenesis inhibitor. J Med Chem 52(3):763–770

    Article  CAS  Google Scholar 

  23. Rubbiani R, Kitanovic I, Alborzinia H, Can S, Kitanovic A, Onambele LA, Stefanopoulou M, Geldmacher Y, Sheldrick WS, Wolber G, Prokop A, Wӧlfl S, Ott I (2010) Benzimidazol-2-ylidene Gold(I) complexes are thioredoxin reductase inhibitors with multiple antitumor properties. J Med Chem 53(24):8608–8618

    Article  CAS  Google Scholar 

  24. Rubbiani R, Can S, Kitanovic I, Alborzinia H, Stefanopoulou M, Kokoschka M, Mönchgesang S, Sheldrick WS, Wölfl S, Ott I (2011) Comparative in vitro evaluation of N-heterocyclic carbene Gold(I) complexes of the benzimidazolylidene type. J Med Chem 54(24):8646–8657

    Article  CAS  Google Scholar 

  25. Meyer A, Bagowski CP, Kokoschka M, Stefanopoulou M, Alborzinia H, Can S, Vlecken DH, Sheldrick WS, Wölfl S, Ott I (2012) On the biological properties of Alkynyl phosphine Gold(I) complexes. Angew Chem Int Ed 51(39):8895–8899

    Article  CAS  Google Scholar 

  26. Ray S, Mohan R, Singh JK, Samantaray MK, Shaikh MM, Panda D, Ghosh P (2007) Anticancer and antimicrobial metallopharmaceutical agents based on palladium, gold, and silver N-heterocyclic carbene complexes. J Am Chem Soc 129(48):15042–15053

    Article  CAS  Google Scholar 

  27. Hickey JL, Ruhayel RA, Barnard PJ, Baker MV, Berners-Price SJ, Filipovska A (2008) Mitochondria-targeted chemotherapeutics: the rational design of gold(I) N-heterocyclic carbene complexes that are selectively toxic to cancer cells and target protein selenols in preference to thiols. J Am Chem Soc 130(38):12570–12571

    Article  CAS  Google Scholar 

  28. Teyssot M-L, Jarrousse A-S, Manin M, Chevry A, Roche S, Norre F, Beaudoin C, Morel L, Boyer D, Mahiou R, Gautier A (2009) Metal-NHC complexes: a survey of anti-cancer properties. Dalton Trans 35:6894–6902

    Article  Google Scholar 

  29. Lemke J, Pinto A, Niehoff P, Vasylyeva V, Metzler-Nolte N (2009) Synthesis, structural characterisation and anti-proliferative activity of NHC gold amino acid and peptide conjugates. Dalton Trans 35:7063–7070

    Article  Google Scholar 

  30. Weaver J, Gaillard S, Toye C, Macpherson S, Nolan SP, Riches A (2011) Cytotoxicity of Gold(I) N-heterocyclic carbene complexes assessed by using human tumor cell lines. Chem Eur J 17(24):6620–6624

    Article  CAS  Google Scholar 

  31. Wang C-H, Shih W-C, Chang HC, Kuo Y-Y, Hung W-C, Ong T-G, Li W-S (2011) Preparation and characterization of amino-linked heterocyclic carbene palladium, gold, and silver complexes and their use as anticancer agents that act by triggering apoptotic cell death. J Med Chem 54(14):5245–5249

    Article  CAS  Google Scholar 

  32. Sivaram H, Tan J, Huynh HV (2012) Syntheses, characterizations, and a preliminary comparative cytotoxicity study of Gold(I) and Gold(III) complexes bearing benzimidazole—and pyrazole-derived N-heterocyclic carbenes. Organometallics 31:5875–5883

    Article  CAS  Google Scholar 

  33. Schuh E, Pflüger C, Citta A, Folda A, Rigobello MP, Bindoli A, Casini A, Mohr F (2012) Gold(I) carbene complexes causing thioredoxin 1 and thioredoxin 2 oxidation as potential anticancer agents. J Med Chem 55(11):5518–5528

    Article  CAS  Google Scholar 

  34. Li G, Huang J, Zhang M, Zhou Y, Zhang D, Wu Z, Wang S, Weng X, Zhou X, Yang G (2008) Bis(benzimidazole)pyridine derivative as a new class of G-quadruplex inducing and stabilizing ligand. Chem Commun 38:4564–4566

    Article  Google Scholar 

  35. Boča M, Jameson RF, Linert W (2011) Fascinating variability in the chemistry and properties of 2,6-bis-(benzimidazol-2-yl)-pyridine and 2,6-bis-(benzthiazol-2-yl)-pyridine and their complexes. Coord Chem Rev 255(1–2):290–317

    Google Scholar 

  36. Serratrice M, Edafe F, Mendes F, Scopelliti R, Zakeeruddin SM, Grätzel M, Santos I, Cinellu MA, Casini A (2012) Cytotoxic gold compounds: synthesis, biological characterization and investigation of their inhibition properties of the zinc finger protein PARP-1. Dalton Trans 41(11):3287–3293

    Article  CAS  Google Scholar 

  37. Hashiguchi BG, Young KJH, Yousufuddin M, Goddard WA III, Periana RA (2010) Acceleration of nucleophilic CH activation by strongly basic solvents. J Am Chem Soc 132(36):12542–12545

    Article  CAS  Google Scholar 

  38. Lin IJB, Vasam CS (2007) Preparation and application of N-heterocyclic carbene complexes of Ag(I). Coord Chem Rev 251(5–6):642–670

    Article  CAS  Google Scholar 

  39. Baker MV, Barnard PJ, Berners-Price SJ, Brayshaw SK, Hickey JL, Skelton BW, White AH (2005) Synthesis and structural characterization of linear Au(I) N-heterocyclic carbene complexes: new analogues of the Au(I) phosphine drug auranofin. J Organomet Chem 690(24–25):5625–5635

    Article  CAS  Google Scholar 

  40. Lee CK, Vasam CS, Huang TW, Wang HMJ, Yang RY, Lee CS, Lin IJB (2006) Silver(I) N-heterocyclic carbenes with long N-Alkyl chains. Organometallics 25(15):3768–3775

    Article  CAS  Google Scholar 

  41. Sheldrick GM (2008) A short history of SHELX. Acta Cryst A64(1):112–122

    Article  Google Scholar 

  42. Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 Years of image analysis. Nat Methods 9(7):671–675

    Article  CAS  Google Scholar 

  43. Sun RW-Y, Li CK-L, Ma D-L, Yan JJ, Lok C-N, Leung C-H, Zhu N, Che C-M (2010) Stable Anticancer Gold(III)-porphyrin complexes: effects of porphyrin structure. Chem Eur J 16(10):3097–3113

    Article  CAS  Google Scholar 

  44. Zou T, Lum CT, Chui SS-Y, Che C-M (2013) Gold(III) complexes containing N-heterocyclic carbene ligands: thiol “switch-on” fluorescent probes and anti-cancer agents. Angew Chem Int Ed 52(10):2930–2933

    Article  CAS  Google Scholar 

  45. Au VK-M, Wong KM-C, Zhu N, Yam VW-W (2009) Luminescent cyclometalated N-heterocyclic carbene-containing Organogold(III) complexes: synthesis, characterization, electrochemistry, and photophysical studies. J Am Chem Soc 131(25):9076–9085

    Article  CAS  Google Scholar 

  46. Gaillard S, Slawin AMZ, Bonura AT, Stevens ED, Nolan SP (2010) Synthetic and structural studies of [AuCl3(NHC)] complexes. Organometallics 29(2):394–402

    Article  CAS  Google Scholar 

  47. de Frémont P, Singh R, Stevens ED, Petersen JL, Nolan SP (2007) Synthesis, characterization and reactivity of N-heterocyclic carbene Gold(III) complexes. Organometallics 26(6):1376–1385

    Article  Google Scholar 

  48. Jothibasu R, Huynh HV, Koh LL (2008) Au(I) and Au(III) complexes of a sterically bulky benzimidazole-derived N-heterocyclic carbene. J Organomet Chem 693(3):374–380

    Article  CAS  Google Scholar 

  49. Petzold H, Sadler PJ (2008) Oxidation induced by the antioxidant glutathione (GSH). Chem Commun 37:4413–4415

    Article  Google Scholar 

  50. Ji S, Guo H, Yuan X, Li X, Ding H, Gao P, Zhao C, Wu W, Wu W, Zhao J (2010) A highly selective OFF-ON red-emitting phosphorescent thiol probe with large stokes shift and long luminescent lifetime. Org Lett 12(12):2876–2879

    Article  CAS  Google Scholar 

  51. Wang H, Wang W-S, Zhang H-S (2001) Spectrofluorimetic determination of cysteine based on the fluorescence inhibition of Cd(II)–8-hydroxyquinoline-5-sulphonic acid complex by cysteine. Talanta 53(5):1015–1019

    Article  CAS  Google Scholar 

  52. Sugio S, Kashima A, Mochizuki S, Noda M, Kobayashi K (1999) Crystal structure of human serum albumin at 2.5 a resolution. Protein Eng 12(6):439–446

    Article  CAS  Google Scholar 

  53. Bhattacharya AA, Grüne T, Curry S (2000) Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. J Mol Biol 303(5):721–732

    Article  CAS  Google Scholar 

  54. Dhar S, Gu FX, Langer R, Farokhzad OC, Lippard SJ (2008) Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles. Proc Natl Acad Sci USA 105(45):17356–17361

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Taotao Zou .

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media Singapore

About this chapter

Cite this chapter

Zou, T. (2016). Gold(III) Complexes Containing N-Heterocyclic Carbene Ligand Serve as Dual Fluorescent Thiol “Switch-On” Probe and Anticancer Agent. In: Anti-Cancer N-Heterocyclic Carbene Complexes of Gold(III), Gold(I) and Platinum(II). Springer Theses. Springer, Singapore. https://doi.org/10.1007/978-981-10-0657-9_3

Download citation

Publish with us

Policies and ethics